Teresa Kaserer

1.1k total citations
33 papers, 732 citations indexed

About

Teresa Kaserer is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Teresa Kaserer has authored 33 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Computational Theory and Mathematics and 8 papers in Pharmacology. Recurrent topics in Teresa Kaserer's work include Computational Drug Discovery Methods (13 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Receptor Mechanisms and Signaling (5 papers). Teresa Kaserer is often cited by papers focused on Computational Drug Discovery Methods (13 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Receptor Mechanisms and Signaling (5 papers). Teresa Kaserer collaborates with scholars based in Austria, United States and United Kingdom. Teresa Kaserer's co-authors include Daniela Schuster, Alex Odermatt, Katharina R. Beck, Muhammad Akram, Mariana Spetea, Nadine J. Ortner, Jörg Striessnig, Helmut Schmidhammer, Aquilino Lantero and Veronika Temml and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Teresa Kaserer

32 papers receiving 723 citations

Peers

Teresa Kaserer

CTM

CMN

PHARM

Olaposi Idowu Omotuyi Nigeria

Cheng Chang United States

Spencer S. Ericksen United States

Helga H.J. Gerets Belgium

Mohammad Mobashir Sweden

Roberto Nuti Italy

Jan Neelissen Sweden

Elias Carvalho Padilha United States

Jordi Rodrigo France

Olaposi Idowu Omotuyi Nigeria

Teresa Kaserer

408 ×1.0

153 ×0.8

CTM

70 ×0.6

CMN

100 ×1.1

81 ×0.9

PHARM

Citations per year, relative to Teresa Kaserer Teresa Kaserer (= 1×) peers Olaposi Idowu Omotuyi

Countries citing papers authored by Teresa Kaserer

Since Specialization

Citations

This map shows the geographic impact of Teresa Kaserer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Kaserer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Kaserer more than expected).

Fields of papers citing papers by Teresa Kaserer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Kaserer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Kaserer. The network helps show where Teresa Kaserer may publish in the future.

Co-authorship network of co-authors of Teresa Kaserer

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Kaserer. A scholar is included among the top collaborators of Teresa Kaserer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Kaserer. Teresa Kaserer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bante, David, Andreas Naschberger, Francesco Costacurta, et al.. (2024). Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir. SHILAP Revista de lepidopterología. 2(1). 23–23. 9 indexed citations

Costacurta, Francesco, David Bante, Xi He, et al.. (2024). Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system. Antiviral Research. 231. 105969–105969. 7 indexed citations

Lieb, Andreas, et al.. (2023). Disruptor: Computational identification of oncogenic mutants disrupting protein-protein and protein-DNA interactions. Communications Biology. 6(1). 720–720. 3 indexed citations

Ortner, Nadine J., et al.. (2023). Ca_v1.3‐selective inhibitors of voltage‐gated L‐type Ca²⁺ channels: Fact or (still) fiction?. British Journal of Pharmacology. 180(10). 1289–1303. 11 indexed citations

Kaserer, Teresa, et al.. (2023). Protocol for predicting drug-resistant protein mutations to an ERK2 inhibitor using RESISTOR. STAR Protocols. 4(2). 102170–102170. 3 indexed citations

Kaserer, Teresa, et al.. (2022). RESISTOR: A New OSPREY Module to Predict Resistance Mutations. Journal of Computational Biology. 29(12). 1346–1352. 4 indexed citations

Lieb, Andreas, et al.. (2021). Functional Characterization of Spinocerebellar Ataxia Associated Dynorphin A Mutant Peptides. Biomedicines. 9(12). 1882–1882. 7 indexed citations

Ortner, Nadine J., Teresa Kaserer, Saskia Biskup, et al.. (2021). Novel CACNA1A Variant p.Cys256Phe Disrupts Disulfide Bonds and Causes Spinocerebellar Ataxia. Movement Disorders. 37(2). 401–404. 5 indexed citations

Ortner, Nadine J., et al.. (2020). De novo CACAN1D Ca2+ channelopathies: clinical phenotypes and molecular mechanism. Pflügers Archiv - European Journal of Physiology. 472(7). 755–773. 44 indexed citations

10.

Kaserer, Teresa, et al.. (2020). Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists. Scientific Reports. 10(1). 13804–13804. 27 indexed citations

11.

Kostaras, Eleftherios, Teresa Kaserer, Pedro Casado, et al.. (2020). A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity. British Journal of Cancer. 123(4). 542–555. 29 indexed citations

12.

Kaserer, Teresa, Angela Wu, Alexandre Mouravlev, et al.. (2019). Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics. Science Advances. 5(4). eaaw1567–eaaw1567. 47 indexed citations

13.

Akram, Muhammad, Teresa Kaserer, Veronika Temml, et al.. (2019). Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11β-hydroxylase and aldosterone synthase. The Journal of Steroid Biochemistry and Molecular Biology. 192. 105358–105358. 13 indexed citations

14.

Grienke, Ulrike, Teresa Kaserer, George Lambrinidis, et al.. (2019). Steroid sulfatase inhibiting lanostane triterpenes – Structure activity relationship and in silico insights. Bioorganic Chemistry. 95. 103495–103495. 13 indexed citations

15.

Kaserer, Teresa & Julian Blagg. (2018). Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer. Cell chemical biology. 25(11). 1359–1371.e2. 13 indexed citations

16.

Kaserer, Teresa, et al.. (2016). Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists. European Journal of Medicinal Chemistry. 124. 49–62. 14 indexed citations

17.

Seebacher, Werner, Armin Presser, Robert Weis, et al.. (2015). Synthesis of new 4-phenylpyrimidine-2(1 H )-thiones and their potency to inhibit COX-1 and COX-2. European Journal of Medicinal Chemistry. 101. 552–559. 8 indexed citations

18.

Kaserer, Teresa, Veronika Temml, Zsófia Kutil, et al.. (2015). Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2. European Journal of Medicinal Chemistry. 96. 445–457. 16 indexed citations

19.

Kaserer, Teresa, et al.. (2015). In Silico Predictions of Drug – Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition – a Comparative Study of Virtual Screening Performance. Molecular Informatics. 34(6-7). 431–457. 16 indexed citations

20.

Grienke, Ulrike, et al.. (2014). Accessing biological actions of Ganoderma secondary metabolites by in silico profiling. Phytochemistry. 114. 114–124. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact